Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site-Reference-Cited by-同舟云学术

Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site

Published:2020-12-01 Issue:12 Volume:6 Page:1931
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Hayashi Hidetoshi¹,Takiguchi Yuichi²,Minami Hironobu³,Akiyoshi Kohei⁴,Segawa Yoshihiko⁵,Ueda Hiroki⁶,Iwamoto Yasuo⁷,Kondoh Chihiro⁸,Matsumoto Koji⁹,Takahashi Shin¹⁰,Yasui Hisateru¹¹,Sawa Toshiyuki¹²,Onozawa Yusuke¹³,Chiba Yasutaka¹⁴,Togashi Yosuke¹⁵,Fujita Yoshihiko¹⁶,Sakai Kazuko¹⁶,Tomida Shuta¹⁷,Nishio Kazuto¹⁶,Nakagawa Kazuhiko¹

Affiliation:

1. Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan

2. Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan

3. Division of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan

4. Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan

5. Department of Medical Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan

6. Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan

7. Department of Medical Oncology, Hiroshima City Hospital Organization, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan

8. Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan

9. Medical Oncology Division, Hyogo Cancer Center, Akashi, Japan

10. Department of Medical Oncology, Tohoku University Hospital, Sendai, Japan

11. Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan

12. Department of Respiratory Medicine and Medical Oncology, Gifu Municipal Hospital, Gifu, Japan

13. Division of Clinical Oncology, Shizuoka Cancer Center, Shizuoka, Japan

14. Clinical Research Center, Kindai University Hospital, Osaka-Sayama, Japan

15. Chiba Cancer Center, Research Institute, Chiba, Japan

16. Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan

17. Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2771755/jamaoncology_hayashi_2020_oi_200076_1606943496.11119.pdf

Reference35 articles.

1. Cancer of unknown primary site.;Pavlidis;Lancet,2012

2. Cancer of unknown primary site.;Varadhachary;N Engl J Med,2014

3. Carcinomas of an unknown primary origin—diagnosis and treatment.;Massard;Nat Rev Clin Oncol,2011

4. Progress in refining the clinical management of cancer of unknown primary in the molecular era.;Rassy;Nat Rev Clin Oncol,2020

5. Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin.;Greco;Ann Oncol,2000

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Utility of¹⁸F-FDG PET/CT in Cancer of Unknown Primary;Journal of Nuclear Medicine;2024-09-05

2. The effect of examining somatic alterations with NGS in patients with solid tumors, on patient management: A single-center experience in Turkey;Journal of Oncology Pharmacy Practice;2024-07-25

3. Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort;npj Precision Oncology;2024-07-18

4. Harnessing Bacterial Membrane Components for Tumor Vaccines: Strategies and Perspectives;Advanced Healthcare Materials;2024-07-04

5. Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary;Molecular Therapy;2024-07